Status:
COMPLETED
Effectiveness and Safety of Topical Hyaluronic Acid of Different Molecular Weights in Xerotic Skin Treatment
Lead Sponsor:
Indonesia University
Conditions:
Xerosis Cutis
Eligibility:
All Genders
60-80 years
Phase:
PHASE3
Brief Summary
The goal of this clinical trial is to compare 0,1% topical low molecular weight (7 kDa) hyaluronic acid with 0,1% high molecular weight (1.800 kDa) hyaluronic acid as therapy of xerotic skin in elderl...
Detailed Description
This clinical trial is conducted to compare the effectiveness and safety between moisturizers containing 0,1% low molecular weight hyaluronic acid, 0,1% high molecular weight hyaluronic acid, and its ...
Eligibility Criteria
Inclusion
- Female or male diagnosed with xerotic skin
- 60-80 years old
- Willing to participate in clinical trial and sign informed consent
Exclusion
- History of hypersensitivity to moisturizer
- Dermatitis or any dermatosis on intervention area in the leg
- Score of erythema and crack more than 2, based on SRRC scoring
Key Trial Info
Start Date :
August 26 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 30 2023
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT06178367
Start Date
August 26 2023
End Date
September 30 2023
Last Update
April 30 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Panti Sosial Tresna Werdha Budi Mulia 3
Jakarta, DKI Jakarta, Indonesia, 12420